Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma

Keith T. Flaherty, Mark A. Rosen, Daniel F. Heitjan, Maryann L. Gallagher, Brian Schwartz, Mitchell D. Schnall, Peter J. O'Dwyer

Research output: Contribution to journalArticlepeer-review

167 Scopus citations

Fingerprint

Dive into the research topics of 'Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences